ABSTRACT Background: The melanin-concentrating hormone receptor 1 (MCHR1) is a G protein-coupled receptor that regulates energy balance and body composition in animal models. Inconsistent effects of MCHR1 polymorphisms on energy homeostasis in humans may partly be attributable to environmental factors. Objectives: We examined the effect of 4 single nucleotide polymorphisms (rs133073, rs133074, rs9611386, and rs882111) in the MCHR1 gene on body composition as well as energy-related lifestyle factors (diet and physical activity). We also examined the effect of gene-lifestyle interactions on body composition. Design: A total of 1153 participants (248 men and 905 women) from the cross-sectional Complex Diseases in the Newfoundland Population: Environment and Genetics (CODING) study were genotyped by using probe-based chemistry validated assays. Diet and physical activity were estimated by using validated frequency questionnaires, and body composition was assessed by using dual-energy X-ray absorptiometry. Results: Three polymorphisms (rs9611386, rs882111, and rs133073) were associated with differences in body-composition measurements (all P , 0.05). There was an interaction between rs9611386 and carbohydrate intake on total mass and waist circumference (both P # 0.01). There was also an interaction between rs9611386 and body mass index categories (normal weight, overweight, and obese) on energy intakes (P = 0.02). A similar interaction was shown with rs882111 (P = 0.02). Interactions were also observed between each of these polymorphisms (rs9611386, rs882111, and rs133073) and physical activity score on body-composition measurements (all P , 0.05). Conclusion: These findings suggest that polymorphisms in the MCHR1 gene are associated with differences in body composition and interact with physiologic and energy-related lifestyle factors.
INTRODUCTION
The melanin-concentrating hormone (MCH) 4 regulates energy intake and expenditure and, thus, is a candidate gene of interest for obesity (1) . MCH acts through 2 G protein-coupled receptors [melanin-concentrating hormone receptor 1 (MCHR1) and MCHR2] expressed in cerebral regions that regulate feeding behavior, energy homeostasis, motivation and reward and, peripherally, in adipose, pancreatic, and colonic tissues (2) . Although humans have both receptors, rodents exhibit only MCHR1 and, thus, are the most extensively studied (1) . Knockout mice for MCHR1 are resistant to diet-induced obesity and have lower weight and adiposity and higher locomotor activity and resting energy expenditure (3, 4) . Although knockout mice are hyperphagic as a possible compensatory mechanism for their heightened energy expenditure (3) (4) (5) , rats treated with MCHR1 agonist have a higher food intake, leptin and insulin concentrations, and fat mass (6) . Thus, studies in rodents have clearly shown that MCHR1 is involved in energy balance.
It is recognized that polymorphisms in genes associated with obesity have a small effect size and that many environmental factors are capable of modulating inherent genetic predispositions (7) . In humans, inconsistent results have been published regarding the association between polymorphisms in the MCHR1 gene and obesity traits (8) (9) (10) (11) (12) . Two rare mutations were observed in young, obese hyperphagic individuals that were not shown in normalweight control subjects of United Kingdom (9) . Another study conducted in obese compared with nonobese children and adolescents from Germany showed a significant association with obesity for an MCHR1 haplotype, but the results were not confirmed in Danish, French, and American cohorts (10) . Single nucleotide polymorphisms (SNPs) 4 in MCHR1 were also studied in 2 unrelated Finnish populations, but none of the SNPs were associated with obesity traits or energy expenditure (11) . Conversely, a protective effect of an MCHR1 SNP for central obesity was observed in Danish men (12) . An SNP was also shown to be less frequent in severely obese children than in control subjects in a French population, which suggested a protective effect against the early onset of obesity (8) . Although studies performed in animals have clearly shown a role for MCHR1 in energy homeostasis, human studies have not convincingly supported a genotype-phenotype association. These inconsistencies may have been partly attributable to environmental factors that hampered the small effect each polymorphism may have on obesity phenotypes. Thus, the goal of this study was to examine the effects of 4 common SNPs (rs882111, rs9611386, rs133073, and rs133074) in the MCHR1 gene on body composition as well as energy-related lifestyle factors (diet and physical activity) and gene-lifestyle interactions in a homogeneous sample of a Canadian Newfoundland population.
SUBJECTS AND METHODS

Subjects
Subjects participated in the Complex Diseases in the Newfoundland Population: Environment and Genetics (CODING) study, which is a large-scale nutrigenomics cross-sectional cohort, performed in the homogeneous population of Newfoundland, Canada (13) . The trial is an on-going study with an average recruitment of 300 participants/y starting in April 2003. All participants who met inclusion and exclusion criteria and were interested in participating in the study were invited to GS's nutrigenomics laboratory at the Faculty of Medicine of Memorial University to sign a consent form, complete questionnaires, and have anthropometric measurements taken. Participants had to be at least third-generation Newfoundlanders and between the ages of 20 and 79 y. Individuals were excluded if they had any serious metabolic, endocrine, or cardiovascular diseases or if they were pregnant. Questionnaires were used to assess general characteristics such as age, sex, smoking, medication use, and menopausal status. This project was approved by the Health Research Ethics Authority of Memorial University.
Body-composition measurements
Anthropometric measurements were taken after a 12-h overnight fast. Weight was measured to the nearest 0.1 kg on a manual scale balance (Health O Meter Inc) while subjects were wearing standardized light clothes without shoes. Height was measured to the nearest 0.1 cm with a fixed stadiometer. BMI was calculated as body weight divided by height squared. Waist and hip circumferences were measured by using a flexible measuring tape to the nearest 0.1 cm at the level of the umbilicus and at the largest circumference between the waist and thighs, respectively. The waist-to-hip ratio was calculated by using these 2 measurements (waist O hip). The whole-body composition was estimated by using dual-energy X-ray absorptiometry (Lunar Prodigy; GE Medical Systems) as previously described (13) . Body composition was expressed as a percentage of body fat, trunk fat, and lean mass (including bone mass) and total mass (kg).
Dietary assessment
Dietary intake was estimated by using the self-administered semiquantitative Willet food-frequency questionnaire (14) . Subjects were asked to indicate how frequently they consumed a given portion or commonly used unit (eg, one egg or one slice of bread) of various foods and beverages per week over the past year (14) . Answers among 9 possible choices that ranged from never to $6 times/d were converted into daily servings of foods, which were used to estimate energy, macronutrient, and micronutrient intakes (NutriBased Clinical Nutrition Manager software, version 8.2.0; CyberSoft Inc).
Physical activity assessment
The validated short habitual physical activity questionnaire developed by Baecker et al (15) was used to estimate physical activity in our subjects. The 29-item questionnaire assessed work occupation, movement, and leisure-time activities (excluding sport and sleeping times) (15) . All responses were coded on a 5-point scale except for the work occupation and type of sports played (15) . The work occupation was coded 1 point for low intensity (eg, clerical work), 3 points for middle intensity (eg, factory work), and 5 points for high intensity (eg, construction work) (15) . The sports index was calculated on the basis of a combination of intensity (eg, bowling , cycling , boxing) and time spent playing that sport (15) . The work occupation, sport, and leisure-time activity indexes were summed up to produce the total physical activity score (15) .
Genotyping
Genomic DNA was isolated from whole blood by using the Wizard Genomic DNA Purification kit (Promega) according to the manufacturer's protocol. The 4 SNPs investigated in the MCHR1 gene were rs133073 (C.T exon 1; silent), rs133074 [C.T 3# untranslated region (UTR)], rs9611386 (A.G 3#UTR), and rs882111 (G.T intergenic/unknown). Tagging SNPs were chosen by using the pairwise r 2 method with an r 2 $ 0.9 and minor allele frequency (MAF) $0.05 by using the HapMap SNP browser (version 3.5; data for the American Utah residents with Northern and Western European ancestry; Applied Biosystems). Reproducibility was assessed by regenotyping a random sample (5%) of our population, and all genotypes matched their initial called genotype.
Statistics
All statistical analyses were performed with SAS software (version 9.3; SAS Institute Inc). Because this trial is an on-going study, we included the 1928 participants for which complete information on outcomes (BMI, total mass, body fat, trunk fat, lean mass, waist circumference, and waist-to-hip ratio), main predictors and interaction terms (interaction between genotype and energy or macronutrient intake or physical activity), and covariates (age, sex, alcohol intake, medication use, energy intake, and physical activity, as appropriate) were available at the time that these analyses were performed. Because the physical activity level was an important predictor (or covariate), and data were not available for 391 participants, the median score of the population (7.25) was imputed to missing data. A potentially inaccurate energy intake was screened out by using the method of McCrory et al (16) . By applying this method, 88% of participants who had completed the food-frequency questionnaire (n = 1865) were included (range: 820-4900 kcal). The method of McCrory et al (16) allows for the exclusion of under reporting and overreporting as well as records that may not be representative of a usual intake. The final sample size included 1153 participants.
Macronutrients were adjusted for total energy by using the nutrient density method (percentage of energy) and the nutrient residual method (nutrients in grams regressed on energy intake) (17) . Both methods yielded similar results, but the nutrient density method (percentage of energy) is shown because it is more easily interpretable.
All variables were normally distributed except for alcohol intake, which was highly skewed [88.6% consumed ,1 drink (14 g)/d]. Thus, alcohol was log transformed to normalize the distribution, but the arithmetic mean and IQR are shown for ease of interpretation. The chi-square test was used to analyze nominal variables, and the Kruskal-Wallis test was used for ordinal outcome variables. Multiple linear regressions were used to test for associations between polymorphisms and body composition as well as lifestyle factors (diet and physical activity) and to test for gene-lifestyle interactions. Except for basic descriptive statistics (general characteristics are shown in Table 1 ) or unless specified, all analyses were adjusted for the following covariates: age, sex, physical activity, alcohol intake, energy intake, and medication use that was susceptible of affecting energy intake or body composition or weight (ie, birth control pill, hormone-replacement therapy, antidepressant drugs, thyroid hormones, or any combination of these drugs). Covariates were chosen because they were associated with or known to affect any of the main predictors and outcomes. Significant results adjusted for covariates are also shown unadjusted (see "Supplemental data" in the online issue) in line with Strengthening of the Reporting of Observational Studies in Epidemiology recommendations (18) .
The deviation of genotype frequencies from Hardy-Weinberg equilibrium was estimated with a chi-square test with 1 df. Because of the rare homozygote genotype frequency for rs9611386 (n = 2) and rs882111 (n = 4), these polymorphisms were analyzed as a dominant model only. Additive, dominant, and recessive models were tested for the 2 other polymorphisms (rs133073 and rs133074). Multiple genetic model testing (8 models in total) was accounted for by using the false-discovery rate (19) . Results that remained significant after the application of this method are stated at the end of the Results section. To deal with linkage disequilibrium between polymorphisms in the MCHR1 gene, haplotype analyses were carried out by using THESIAS software (version 3.1; http://ecgene.net/genecanvas/ uploads/THESIAS3.1/Documentation3.1.htm) (20) . The THESIAS program is a maximum-likelihood-based program that applies a stochastic-Expectation-Maximization algorithm for simultaneously inferring haplotypes and testing their association with the phenotype (21) . Covariate-adjusted associations between haplotypes and the phenotype of interest were tested by using the likelihood ratio test.
RESULTS
Genotype and haplotype frequencies
MCHR1 genotype frequencies were 35.6%, 48.1%, and 16.4% for TT, TC, and CC genotypes respectively, for the rs133073 (MAF: 40.4%), 27.0%, 48.2%, and 24.8% for CC, CT, and TT genotypes, respectively, for the rs133074 (MAF: 48.9%), 89.5%, 10.3%, and 0.2% for AA, AG, and GG genotypes, respectively, for the rs9611386 (MAF: 5.3%), and 85.3%, 14.3%, and 0.4% for GG, GT, and TT genotypes, respectively, for the rs882111 (MAF: 7.5%). Genotype frequencies did not deviate from Hardy-Weinberg equilibrium.
There were 6 haplotypes with a frequency .1%. These haplotypes were made of the 4 SNPs in order of appearance on the MCHR1 gene (rs133073, rs133074, rs9611386, and rs882111) as follows: TCAG (46.1%; R 2 = 0.97), CTAG (36.0%; R 2 = 0.97), TTAG (6.9%; R 2 = 0.95), TTGT (4.2%; R 2 = 0.86), CCAG (3.1%; R 2 = 0.89), and TCAT (1.6%; R 2 = 0.77).
Effect of MCHR1 polymorphisms on general characteristics
General characteristics of the population are shown in Table 1 by MCHR1 genotypes. Differences between the physical activity score were observed for the rs882111 SNP where carriers of the GT genotype had a significantly higher physical activity score than did subjects with the GG genotype but only in the unadjusted model (unadjusted P = 0.03, adjusted P = 0.07 for age, sex, energy intake, alcohol intake, and medication use; Table 1 ). There was also a difference in the physical activity score between the reference TCAG haplotype and CCAG haplotype that differed only by the first allele (rs133073) [difference 6 SE: unadjusted, 20.35 6 0.12 (P = 0.003); adjusted, 0.37 6 0.13 (P = 0.003)], although the overall likelihood ratio test for the haplotype-phenotype association was not significant (unadjusted P = 0.09, adjusted P = 0.11).
Effect of MCHR1 polymorphisms on body-composition measurements
Three polymorphisms (rs9611386, rs882111, and rs133073) in the MCHR1 gene were associated with differences in several body-composition measurements mostly when covariates were accounted for in the models (age, sex, physical activity, energy intake, alcohol intake, and medication use). See Supplemental Table 1 under "Supplemental data" in the online issue for unadjusted analyses. Carriers of the minor G allele of the rs9611386 polymorphism compared with carriers of the wildtype AA genotype had higher BMI (in kg/m 2 ; mean 6 SEM: 27.3 6 0.5 compared with 26.4 6 0.2, respectively; adjusted P = 0.03), total mass (73.9 6 1.3 compared with 71.4 6 0.7 kg, respectively; adjusted P = 0.04), body fat (36.1 6 0.7 compared with 34.8 6 0.4%, respectively; adjusted P = 0.04), and lower lean mass (60.3 6 0.6 compared with 61.5 60.3%, respectively; adjusted P = 0.04). A similar effect was observed for the rs882111 polymorphism whereby carriers of the minor T allele compared with carriers of the wild-type GG genotype had higher body fat (36.0 6 0.6 compared with 34.8 6 0.4%, respectively; adjusted P = 0.03) and a lower percentage of lean mass (60.4 6 0.6 compared with 61.5 6 0.3%, respectively; adjusted P = 0.04). However, for the rs133073 polymorphism, homozygous for the minor C allele compared with carriers of the major T allele had lower total mass (70.0 6 1.1 compared with 72.0 6 0.7 kg, respectively; adjusted P = 0.04). Significant differences were also observed for body fat and lean mass in unadjusted models only (both unadjusted P = 0.03; both adjusted P = 0.07; see Supplemental Table 1 under "Supplemental data" in the 
Smoking (yes) [n (%)]
137 (12) 55 (13) 61 (11) 21 (11) 42 (14) 62 (11) 33 (12) 121 (12) 16 (13) 0 (0) 117 (12) 20 ( (17) 62 (15) 105 (19) 31 (16) 50 (16) 87 (16) 61 (21) 173 (17) 25 (21) 0 (0) 164 (17) 34 ( 294 (72) 418 (75) 136 (72) 218 (70) 419 (75) 211 (74) 754 (73) 92 (77) 2 (100) 720 (73) 124 (75) 4 (100) BCP 112 (10) 44 (11) 49 (9) 19 (10) 29 (9) 58 (10) 25 (9) 99 (9) 13 (11) 0 (0) 93 (9) 19 (12) 0 (0) HRT 39 (3) 21 (5) 13 (2) 5 (3) 18 (6) 14 (3) 7 (2) 38 (4) 1 (1) 0 (0) 36 (4) 3 (2) 0 (0) Antidepressant 65 (6) 21 (5) 30 (6) 17 (7) 20 (7) 27 (5) 18 (6) 62 (6) 3 (2) 0 (0) 58 (6) 7 (4) 0 (0)
Thyroid hormone 57 (5) 21 (5) 25 (5) 11 (6) 16 (5) 22 (4) 19 (7) 49 (5) 8 (7) 0 (0) 50 (5) 7 (4) 0 (0)
9 (2) 19 (3) 4 (2) 10 (3) 16 (3) 6 (2) 30 (3) 2 (2) 0 (0) 27 (3) 5 (3)
Nominal variables were tested by using the chi-square test, the ordinal variable obesity status was tested by using the Kruskal-Wallis test, and continuous variables were tested by using a general linear model as a genetic additive model. BCP, birth control pill; HRT, hormone-replacement therapy; WC, waist circumference; WHR, waist-to-hip ratio. Because alcohol intake was highly skewed, medians (IQRs) are shown, but log transformed data were used to calculate the P value.
4
Significantly different from the wild-type genotype, P , 0.05.
5
Calculated by using the questionnaire developed by Baecker et al (15) . Table 2 , when individual haplotypes were compared with the reference group (TCAG; all major alleles), subjects carrying one copy of the TTGT haplotype (which contains 3 minor alleles) had significantly higher BMI, total mass, body fat, trunk fat, waist circumference (all adjusted P # 0.02; Table 2 ) and lower lean mass (adjusted P = 0.005). However the global likelihood ratio test for the haplotype-phenotype association was significant for BMI only (adjusted P = 0.01) and showed a trend for total mass, percentage of body fat, and percentage of lean mass (all adjusted P # 0.08). The global likelihood ratio test was not significant for any measurement of unadjusted analyses (see Supplemental Table 2 under "Supplemental data" in the online issue).
MCHR1 POLYMORPHISMS AND ENERGY BALANCE online issue). No difference between genotypes was shown for other body-composition measurements (data not shown). As shown in
Effect of MCHR1 polymorphisms on dietary intake
Differences between energy and alcohol intakes were observed for 2 SNPs but only in unadjusted models. In the dominant model, carriers of the minor G allele for the rs9611386 had a marginally higher energy intake than did subjects with the AA wild-type genotype (mean 6 SE: 2130 6 62 compared with 2003 6 21 kcal, respectively; unadjusted P = 0.05, adjusted P = 0.06 for age, sex, physical activity, alcohol intake, and medication use). Unadjusted alcohol intake also differed between rs133074 genotypes (unadjusted P = 0.02, adjusted P = 0.06 for age, sex, physical activity, energy intake, and medication use; Table 1 ). No differences between genotypes or haplotypes were observed for carbohydrate, protein, or fat. When energy intake was examined between normal weight, overweight, and obese individuals, as expected, there was a significantly higher energy intake with increasing BMI categories in subjects with the wild-type AA genotype for rs9611386 ( Figure 1A) . However, there was no difference in energy intake between BMI categories in individuals carrying the variant G allele (unadjusted P-interaction = 0.007, adjusted P-interaction = 0.02). A similar effect was observed for rs882111 (both unadjusted and adjusted P-interaction = 0.02; Figure 1B ). There was no interaction between haplotypes and BMI categories on energy intake (data not shown). However, the 2 haplotypes that contained the minor allele of either the rs9611386 or rs882111 TTGT (4.2%) and TCAT (1.6%) were of low frequency.
Gene 3 diet interactions on body-composition measurements
Because macronutrients are known to have varying satiety effects (protein . fat . carbohydrate) (22), we examined interactions between MCHR1 polymorphisms and macronutrient intake on body-composition measurements. We observed interactions between rs9611386 and carbohydrate intake for total mass (unadjusted P-interaction = 0.05, adjusted P-interaction = 0.009 for age, sex, physical activity, energy intake, alcohol intake, and medication use) and waist circumference (unadjusted P-interaction = 0.05, adjusted P-interaction = 0.01). The negative association between total mass and carbohydrate intake was more pronounced in carriers of the minor G allele than in those with those with the wild-type AA genotype (adjusted b 6 SE: 20.52 6 0.13 compared with 20.17 6 0.04 kg/percentage of energy, respectively; both P , 0.0001). A similar effect was observed for waist circumference (adjusted b 6 SE; 20.47 6 0.13 compared with 20.14 6 0.04 cm/percentage of energy, respectively; both P , 0.0007).
There were similar interactions with fat intake for total mass and waist circumference as well (unadjusted P-interaction = 0.14 and 0.04 and adjusted P-interaction = 0.04 and 0.02, respectively). Carbohydrate and fat were highly negatively correlated (r = 20.84; P , 0.0001), and thus, similar but inverse associations were observed for fat intake (data not shown). When the gene-nutrient interaction was tested including all nutrients (carbohydrate, fat, and protein) in a nonisocaloric model (g/d; energy-partition model), interactions remained significant with carbohydrate for total mass and waist circumference (unadjusted P = 0.05 for both and adjusted P = 0.05 and 0.04, respectively), but not for fat (unadjusted P = 0.57 and 0.42 and adjusted P = 0.35 and 0.39, respectively), which suggested that the effect was driven by carbohydrate rather than fat.
Gene 3 physical activity interactions on body-composition measurements
Interactions were observed between 3 SNPs (rs133073, rs9611386, and rs882111) and physical activity on different measurements of body composition (adjusted values for age, sex, energy intake, alcohol, and medication use are shown in Table 3 ; Table 3 under "Supplemental data" in the online issue for unadjusted values). At higher physical activity scores, carriers of the minor C allele for the rs133073 had significantly lower BMI, total mass, body fat, trunk fat, waist circumference, and waist-to-hip ratio but had higher lean mass (Table 3) . However, in individuals with the wild-type TT genotype, no association or smaller effects were observed for the same body-composition measurements (Table 3) . Conversely, interactions between both rs9611386 and rs882111 SNPs and with physical activity on several body-composition measurements were observed, but associations were significant only for carriers of wild-type genotypes and not for carriers of the minor allele (Table 3) . No significant interaction was observed for the SNP rs133074. The relation between physical activity level and BMI also varied between haplotypes (unadjusted P = 0.05, and adjusted P-interaction = 0. categories [normal: ,25 (white bars); overweight: 25-29.9 (gray bars); obese; $30 (black bars)] on energy intake [unadjusted P-interaction = 0.007 and adjusted P-interaction = 0.02 for age, sex, physical activity, alcohol intake, and medication use for rs9611386 (A) and both unadjusted and adjusted P-interaction = 0.02 for rs882111 (B)]. Interactions were tested by using a general linear model, and within-group comparisons were performed with the contrast statement. 1 Physical activity score was calculated by using the questionnaire developed by Baecker et al (15) . WC, waist circumference; WHR, waist-to-hip ratio.
2 P values for differences in slopes between genotypes (interaction). Values were determined by using a general linear model adjusted for age, sex, alcohol intake, medication use, and energy intake.
3 Slope (b) 6 SE by genotype (dominant model) (all such values).
4 P values for a slope different from zero.
We applied the false discovery rate for multiple genetic model testing on the 8 models tested (dominant model for rs133073 and rs133074 and additive, dominant, and recessive models for rs9611386 and rs882111). The interaction between rs133073 and the physical activity score on BMI (P = 0.01), waist circumference (P = 0.01), and waist-to-hip ratio (P = 0.04) remained significant. Other results had a probability $0.05 when the false discovery rate was accounted for.
DISCUSSION
The aim of this study was to investigate the effect of 4 common SNPs (rs133073, rs133074, rs9611386, and rs882111) in the MCHR1 gene on body composition as well as energy-related lifestyle factors (diet and physical activity) and gene-lifestyle interactions in the Complex Diseases in the Newfoundland Population: Environment and Genetics study. We showed that the rs9611386 SNP, in particular, modified body-composition measurements and interacted with BMI categories to alter energy intake as well as with carbohydrate intake and physical activity to affect body-composition measurements. The rs9611386 SNP is located in the 3#UTR, which could affect messenger RNA stability and translation efficacy. When multiple genetic testing was corrected for by using the false discovery rate, only the interaction between rs133073 and the physical activity score on BMI, waist circumference, and the waist-to-hip ratio remained significant. The rs133073 is a silent SNP located in exon 1 but is in strong linkage disequilibrium with rs133072, which introduces an amino acid change in the N-terminus of the MCHR1 and may be the causal locus (10) .
The effect of SNPs in the MCHR1 gene on obesity traits in humans were studied in several populations and revealed inconsistent results with either protective, deleterious, or no effect on body composition or obesity status (8) (9) (10) (11) (12) . Our findings suggested that inconsistencies between study results might have been partly explained by lifestyle factor that may mask the genotypic effect if not taken into account. For example, individuals carrying the rs133073 minor allele or the wild-type genotype for the rs9611386 or rs882111 SNPs had lower body-composition measurements at higher physical activity scores, whereas subjects with the alternative genotype seemed to be less or not responsive to physical activity. Consistently, the difference in the physical activity level between haplotypes was only observed between the reference haplotype TCAG and in subjects carrying the minor allele for the rs133073 and the major alleles for the rs9611386 and rs882111 CTAG. Animal studies have shown that knockout mice for MCHR1 have higher locomotor activity and are resistant to weight gain compared with wild-type mice (3, 23) . This evidence would support our findings whereby carriers of a particular haplotype (CTAG), who may have less MCHR1 activity, would be more resistant to weight and fat gain when more physically active. In subjects carrying the minor allele for rs9611386 and rs882111, no associations between BMI and energy intake or physical activity and body composition were observed, which suggested that these subjects are resistant to internal physiologic or external environmental cues.
In the current study, we observed gene-carbohydrate interactions on total mass and waist circumference. A negative association was shown between carbohydrate intake and total mass as well as with waist circumference, but the effect was more pronounced in carriers of the minor G allele of the rs9611386 SNP compared with the wild-type AA genotype. There was also an interaction with fat intake, but fat and carbohydrate were highly correlated. The following different models were tested to elucidate whether the effect was driven by carbohydrate or fat: 2 isocaloric models with the nutrient density and residual methods and one nonisocaloric model with the energy partition method (17) . In isocaloric models, interactions were significant when a higher carbohydrate intake was compensated by a lower fat intake (or vice versa) while keeping protein constant. However, in the nonisocaloric model, in which higher energy coming from carbohydrate (or from fat in a separate model) that was not compensated for by lower energy from other nutrients, interactions were only significant with carbohydrate, which suggested that the effect was driven by this macronutrient. In lateral hypothalamic MCH neurons of mice, increasing physiologic doses of extracellular glucose, which could mimic changes from food intake, reversibly enhanced electrical excitability (cell depolarization) and increased membrane resistance (24) . Because MCH neurons innervate areas of the brain that control energy balance and metabolism, our results suggest that the effect of MCH on total mass and waist circumference at higher glucose intake differ between genotypes.
Because animal studies showed a role of MCHR1 in energy intake, we tested the effect of SNPs in this gene on energy intake. Although no effect of SNPs on energy intake was observed per se, a gene-BMI interaction was shown in this population. As expected, with increasing BMI categories, participants had higher energy intakes in subjects with the wild-type genotype for the rs9611386 and rs882111, but no difference was shown in carriers of the minor allele for both SNPs. Stepanow et al (25) revealed an allele-and BMI-specific DNA methylation pattern of the MCHR1 gene, and thus, it is possible that leaner carriers of these minor alleles have a differential methylation pattern and, thereby, gene expression that resulted in a higher energy intake compensated by higher energy expenditure. Knockout mice for MCHR1 are hyperphagic but also hypermetabolic and resistant to diet-induced obesity (3, 4, 23) , which is consistent with our result whereby carriers of minor alleles, who may have reduced MCHR1 production or activity, ate as much as their overweight and obese counterparts without having the associated weight gain.
Our study had several strengths including the design, which was meant to examine gene-diet interactions in a homogeneous sample of both men and women. Major limitations of the study were that physical activity and diet were not measured directly but estimated by using questionnaires. However, both questionnaires were validated and have been widely used instruments in epidemiologic studies. In any case, these limitations hampered the real associations observed or increased the chance of not finding an effect if there was one (type II error). Our study was performed in a homogenous sample of the Eastern Canadian population and may, thus, not be generalizable to other populations.
In conclusion, the current study reveals that polymorphisms in the MCHR1 gene modulate body-composition measurements, and these effects were modified by lifestyle factors, such as diet and physical activity, and physiologic factors, such as BMI. Drugs targeting MCHR1 have been widely studied but have not been commercialized partly because of safety issues, side effects, and cardiovascular risk (26) . Our findings suggest that alternative strategies, such as personalized advice on macronutrient intake and physical activity according to MCHR1 genotype, may be envisioned for weight management in the future. In vivo functional studies are required to better understand mechanisms of action and the replication of results in other cohorts, and subsequent clinical trials are warranted before implementing genotype-specific personalized lifestyle recommendations.
